ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $125 | -99.8% | 10,370 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $67,000 | -68.5% | 10,370 | -77.7% | 0.00% | -50.0% |
Q2 2022 | $213,000 | +73.2% | 46,532 | +439.1% | 0.00% | +100.0% |
Q4 2021 | $123,000 | -58.7% | 8,631 | -36.3% | 0.00% | 0.0% |
Q3 2021 | $298,000 | – | 13,541 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 1,355,925 | $2,955,917 | 2.56% |
Susquehanna International Group Ltd. | 113,526 | $247,487 | 0.14% |
XTX Topco Ltd | 151,620 | $330,532 | 0.07% |
Corsair Capital Management | 47,256 | $103,018 | 0.04% |
Diametric Capital, LP | 14,314 | $31,205 | 0.02% |
Draper Asset Management, LLC | 5,320 | $11,598 | 0.02% |
ETF MANAGERS GROUP, LLC | 68,940 | $150,289 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $12,267 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 506,255 | $1,103,636 | 0.00% |
Apollon Wealth Management, LLC | 20,000 | $43,600 | 0.00% |